SUBSCRIBE
SUBSCRIBE
News   Business

Biogen Idec, Inc. (Massachusetts) Reports Third Quarter 2010 Results

October 26, 2010 | 
1 min read

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB), a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today announced its third quarter 2010 results.

Earnings
Biogen
MORE ON THIS TOPIC
vintage textured collage with symbols of New York City
Tariffs
Biotech’s Next Phase Will Be All-American: Pitchbook
April 17, 2025
 · 
2 min read
 · 
Annalee Armstrong
Closeup of businessman give money to robot. Man pass banknote bribe to robotic assistant. AI and technology. Vector illustration.
Artificial intelligence
Sanofi Bets More Than $1.8 Billion in Biobucks on AI-Developed Bispecifics
April 17, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Find understanding between people. Reach your opponent. Building a bridge of understanding and reasoning. Discover common ground. Pave way for cooperation or peaceful disagreement. Resolving conflict
Mergers & acquisitions
Bluebird’s Second Suitor, Ayrmid, Fails To Produce an Offer
April 16, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Art 3d banner collage of business people dollar roll cooperation success payment capital profit transaction money corruption.
Rare diseases
Glycomine Gets $115M Series C for Rare Disease, Aims for Phase II Launch Mid-Year
April 16, 2025
 · 
2 min read
 · 
Dan Samorodnitsky